Impact of dabigatran on routine and specific coagulation assays in patients treated by dabigatran.

被引：0
|
作者：
Gemen, E. [1 ]
Kariman, A. [1 ]
Van Dijk, J. [1 ]
Van Eck, M. [1 ]
Pequeriaux, N. [1 ]
机构：
[1] Jeroen Bosch Hosp, Shertogenbosch, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 702
页数：2
相关论文
共 50 条
  • [21] Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran
    Kanda, Gurbaksh Singh
    Ho, Wai Khoon
    Rodrigues, Christopher
    Bousounis, Anna
    Hogan, Chris
    PATHOLOGY, 2021, 53 (05) : 623 - 627
  • [22] Laboratory coagulation assays and ROTEM thromboelastography in monitoring the reversal of dabigatran with FEIBA and haemofiltration
    Leong, J.
    Thomson, E.
    Ali, A.
    Jarrold, U.
    Kanagasabapathy, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1119 - 1119
  • [23] Poststroke impairment outcome and pre-existent cerebral lesions in cardioembolic stroke and atrial fibrillation (AF) patients treated with dabigatran.
    Deme, S. M.
    Ioncu, D. S.
    Hreniuc, N. C.
    Jianu, D. C.
    CEREBROVASCULAR DISEASES, 2014, 37 : 273 - 273
  • [24] Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
    Lindahl, Tomas L.
    Baghaei, Fariba
    Blixter, Inger Fagerberg
    Gustafsson, Kerstin M.
    Stigendal, Lennart
    Sten-Linder, Margareta
    Strandberg, Karin
    Hillarp, Andreas
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) : 371 - 378
  • [25] Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests
    Cho, Han-Jin
    Kang, Yoon Jung
    Sung, Sang Min
    Ahn, Sung-Ho
    Jung, Yo Han
    Lee, Kyung-Yul
    Seo, Jung Hwa
    Han, Sang Won
    Park, Joong Hyun
    Choi, Hye-Yeon
    Kwon, Jee-Hyun
    Kim, Wook-Joo
    Park, Hyung Jong
    Choi, Jin Kyo
    Nam, Hyo Suk
    Heo, Ji Hoe
    Kim, Young Dae
    PLOS ONE, 2020, 15 (10):
  • [26] Adherence in patients with atrial fibrillation treated with dabigatran
    Grzesk, Grzegorz
    Janiszewska, Ewa
    Malinowski, Bartosz
    Kubica, Aldona
    Wicinski, Michal
    KARDIOLOGIA POLSKA, 2018, 76 (11) : 1562 - 1563
  • [27] BETRIXABAN: IMPACT ON ROUTINE AND SPECIFIC COAGULATION ASSAYS - PRACTICAL LABORATORY GUIDANCE
    Siriez, Romain
    Evrard, Jonathan
    Dogne, Jean-Michel
    Pochet, Lionel
    Gheldof, Damien
    Chatelain, Bernard
    Vancraeynest, Christelle
    Devel, Philippe
    Guldenpfennig, Maite
    Devroye, Celia
    Mullier, Francois
    Douxfils, Jonathan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 137 - 137
  • [28] Edoxaban: Impact on routine and specific coagulation assays A practical laboratory guide
    Douxfils, Jonathan
    Chatelain, Bernard
    Chatelain, Christian
    Dogne, Jean-Michel
    Mullier, Francois
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 368 - 381
  • [29] Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
    Douxfils, Jonathan
    Chatelain, Christian
    Chatelain, Bernard
    Dogne, Jean-Michel
    Muller, Francois
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) : 283 - 294
  • [30] Impact of edoxaban on a large panel of routine of more specific coagulation assays
    Douxfils, J.
    Bianco, T. D.
    Baudar, J.
    Lessire, S.
    Chatelain, B.
    Dogne, J-M
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 297 - 297
12345